137 related articles for article (PubMed ID: 34342)
1. Diagnosis and treatment: drugs five years later. Amoxicillin.
Neu HC
Ann Intern Med; 1979 Mar; 90(3):356-60. PubMed ID: 34342
[TBL] [Abstract][Full Text] [Related]
2. Amoxycillin: A review of its antibacterial and pharmacokinietic properties and therapeutic use.
Brogeden RN; Speight TM; Avery GS
Drugs; 1975; 9(2):88-140. PubMed ID: 1126306
[TBL] [Abstract][Full Text] [Related]
3. Amoxicillin in the treatment of lower respiratory infections.
May JR; Ingold H
Adv Clin Pharmacol; 1974; 7():85-90. PubMed ID: 4619755
[No Abstract] [Full Text] [Related]
4. [Amoxicillin: microbiological, pharmacokinetic and therapeutic aspects].
Motta G; Malberti R
Farmaco Prat; 1975 Aug; 30(8):357-73. PubMed ID: 1041491
[No Abstract] [Full Text] [Related]
5. [Talampicillin hydrochloride: Comparison with amoxicillin and ampicillin in the antibacterial activity and pharmacokinetics (author's transl)].
Tachibana A; Ohtani K; Komiya M; Naito S; Shimizu C; Yano K
Jpn J Antibiot; 1978 Mar; 31(3):166-76. PubMed ID: 246947
[TBL] [Abstract][Full Text] [Related]
6. A clinical comparison of ampicillin, ampicillin esters (bacampicillin and pivampicillin) and amoxycillin in acute exacerbations of chronic bronchitis.
Maesen F; Davies B
Infection; 1979; 7 Suppl 5():S483-6. PubMed ID: 315931
[TBL] [Abstract][Full Text] [Related]
7. Amoxicillin-potassium clavulanate, a beta-lactamase-resistant antibiotic combination.
Stein GE; Gurwith MJ
Clin Pharm; 1984; 3(6):591-9. PubMed ID: 6391783
[TBL] [Abstract][Full Text] [Related]
8. Aminopenicillins - clinical pharmacology and use in disease states.
Neu HC
Int J Clin Pharmacol Biopharm; 1975 Mar; 11(2):132-44. PubMed ID: 1095502
[TBL] [Abstract][Full Text] [Related]
9. [Current status of PRSP and BLNAR].
Hotomi M; Yamanaka N
Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():441-7. PubMed ID: 17455659
[No Abstract] [Full Text] [Related]
10. [Role of amoxicillin in antibiotic therapy].
Nouv Presse Med; 1975 Oct; 4(34):2467-73. PubMed ID: 1105413
[No Abstract] [Full Text] [Related]
11. Treatment failure in Haemophilus influenzae due to a beta-lactamase low-level ampicillin-resistant organism.
van der Ploeg V; Gelinck LB; Jonkers IJ; Mourer JS; van Dam AP
J Infect; 2008 Dec; 57(6):485-8. PubMed ID: 18775568
[TBL] [Abstract][Full Text] [Related]
12. Stability in the presence of widespread beta-lactamases. A prerequisite for the antibacterial activity of beta-lactam drugs.
Schito GC; Pesce A; Debbia EA
Drugs; 1994; 47 Suppl 3():1-8; discussion 8-9. PubMed ID: 7518761
[TBL] [Abstract][Full Text] [Related]
13. [In vitro and in vivo activity of a combination of clavulanic acid and amoxicillin against Klebsiella pneumoniae producing extended broad-spectrum betalactamase (CTX-1, SHV-3, SHV-4)].
Migueres ML; Ronco E; Guenounou M; Philippon A
Pathol Biol (Paris); 1989 May; 37(5):397-401. PubMed ID: 2674869
[TBL] [Abstract][Full Text] [Related]
14. Amoxicillin/clavulanate therapy of respiratory tract infections: a microbiologic perspective.
Cunha BA
Clin Ther; 1992; 14(3):418-25. PubMed ID: 1638583
[TBL] [Abstract][Full Text] [Related]
15. In vivo activity of amoxicillin and ampicillin against gram-positive bacteria: results of prophylactic studies.
Grunberg E; Cleeland R; Beskid G; DeLorenzo W
J Infect Dis; 1978 Dec; 138(6):872-6. PubMed ID: 33219
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobiol therapy: therapeutic recommendations and a review of newer drugs. Part I. Therapy of infectious conditions.
McCracken GH; Eichenwald HF
J Pediatr; 1974 Sep; 85(3):297-312. PubMed ID: 4610417
[No Abstract] [Full Text] [Related]
17. [Therapeutic use of amoxicillin in pediatrics].
Iodi S; Panzetti G
Clin Ter; 1978 Mar; 84(6):619-25. PubMed ID: 348386
[No Abstract] [Full Text] [Related]
18. Probability of achieving requisite pharmacodynamic exposure for oral beta-lactam regimens against Haemophilus influenzae in children.
Pichichero ME; Doern GV; Kuti JL; Nicolau DP
Paediatr Drugs; 2008; 10(6):391-7. PubMed ID: 18998749
[TBL] [Abstract][Full Text] [Related]
19. [Morphological changes in penicillin-resistant Streptococcus pneumoniae and beta-lactamase-nonproducing, ampicillin-resistant Haemophilus influenzae after exposure to oral antibacterial agents].
Chiba N; Morozumi M; Ubukata K
Jpn J Antibiot; 2012 Oct; 65(5):323-34. PubMed ID: 23383434
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of cefdinir against respiratory pathogens isolated in Sicily with reference to beta-lactamase production.
Blandino G; Aleo G; Caccamo F; Nicolosi VM; Siracusa V; Speciale A
J Chemother; 1996 Jun; 8(3):193-9. PubMed ID: 8808715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
